Literature DB >> 18982011

Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor.

A K S Eriksson1, V van Harmelen, B M Stenson, G Aström, K Wåhlén, J Laurencikiene, M Rydén.   

Abstract

OBJECTIVE: Levels of the vascular peptide endothelin-1 (ET-1) are significantly elevated in obesity. Adipose tissue-derived ET-1 attenuates insulin-mediated antilipolysis in human visceral adipocytes through the activation of the ET receptor B (ET(B)R), thereby linking ET-1 to insulin resistance. Whether ET-1 has direct effects on lipolysis in human adipocytes is not known. RESEARCH DESIGN AND
SUBJECTS: Endothelin-1 receptor (ETR) mRNA expression was determined by quantitative PCR in 130 non-obese and obese subjects. ET-1 mRNA in different adipose tissue regions was also assessed. ETR protein expression was analyzed by western blotting in 37 subjects. The effect of ET-1 on lipolysis was assessed in freshly isolated adipocytes and in vitro differentiated adipocytes from human donors.
RESULTS: Freshly isolated human adipocytes incubated with different concentrations of ET-1 showed no acute effect on lipolysis. In contrast, a 24 h incubation in primary cultures of human adipocytes resulted in a significant 50% increase in lipolysis. This effect was concentration dependent and could be mimicked by an agonist of the ET(A) receptor but not with a selective ET(B)R agonist. Adipocyte differentiation was not affected by any of the agonists. In subcutaneous (s.c.) adipose tissue from 19 non-obese and 18 obese subjects, the protein expression of ET(A)R was significantly higher in obese subjects whereas there was no difference in ET(B)R expression. Interestingly, the differences in protein expression were not observed at the mRNA level as ET(A)R expression was similar between lean and obese subjects.
CONCLUSION: Long-term but not acute incubation of human adipocytes with ET-1 results in a significant increase in lipolysis. This appears to be mediated through the activation of ET(A)R, demonstrating a yet another receptor-specific effect of ET-1. In addition, the protein expression of ET(A)R is increased in s.c. adipose tissue in obesity, possibly through post-transcriptional mechanisms. An increased effect of ET-1 could be a mechanism that contributes to increased basal lipolysis in human obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982011     DOI: 10.1038/ijo.2008.212

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  21 in total

1.  Arsenic-stimulated lipolysis and adipose remodeling is mediated by G-protein-coupled receptors.

Authors:  D Yesica Garciafigueroa; Linda R Klei; Fabrisia Ambrosio; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2013-05-06       Impact factor: 4.849

2.  Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells.

Authors:  Ming-Song Lee; Jesse Wang; Huihua Yuan; Hongli Jiao; Tsung-Lin Tsai; Matthew W Squire; Wan-Ju Li
Journal:  FASEB J       Date:  2018-08-10       Impact factor: 5.191

3.  Elevated plasma endothelin-1 is associated with reduced weight loss post vertical sleeve gastrectomy.

Authors:  Haley N Jenkins; London J Williams; Adam Dungey; Kenneth D Vick; Bernadette E Grayson; Joshua S Speed
Journal:  Surg Obes Relat Dis       Date:  2019-04-09       Impact factor: 4.734

Review 4.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

5.  Overproduction of endothelin-1 impairs glucose tolerance but does not promote visceral adipose tissue inflammation or limit metabolic adaptations to exercise.

Authors:  Thomas J Jurrissen; Zachary I Grunewald; Makenzie L Woodford; Nathan C Winn; James R Ball; Thomas N Smith; Andrew A Wheeler; Arthur L Rawlings; Kevin F Staveley-O'Carroll; Yan Ji; William P Fay; Pierre Paradis; Ernesto L Schiffrin; Victoria J Vieira-Potter; Paul J Fadel; Luis A Martinez-Lemus; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-16       Impact factor: 4.310

6.  Endothelin receptor blockade blunts the pressor response to acute stress in men and women with obesity.

Authors:  Cassandra C Derella; Anson M Blanks; Xiaoling Wang; Matthew A Tucker; Chase Horsager; Jin Hee Jeong; Paula Rodriguez-Miguelez; Jacob Looney; Jeffrey Thomas; David M Pollock; Ryan A Harris
Journal:  J Appl Physiol (1985)       Date:  2021-11-11

7.  Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model.

Authors:  Toshiaki Okamoto; Masahiko Koda; Kennichi Miyoshi; Takumi Onoyama; Manabu Kishina; Tomomitsu Matono; Takaaki Sugihara; Keiko Hosho; Junichi Okano; Hajime Isomoto; Yoshikazu Murawaki
Journal:  World J Hepatol       Date:  2016-08-08

8.  Arsenic activates endothelin-1 Gi protein-coupled receptor signaling to inhibit stem cell differentiation in adipogenesis.

Authors:  Linda R Klei; D Yesica Garciafigueroa; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2012-11-14       Impact factor: 4.849

9.  Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase.

Authors:  Anne Briançon-Marjollet; Denis Monneret; Marion Henri; Florence Hazane-Puch; Jean-Louis Pepin; Patrice Faure; Diane Godin-Ribuot
Journal:  J Physiol       Date:  2016-01-20       Impact factor: 5.182

10.  Loss of endothelin type B receptor function improves insulin sensitivity in rats.

Authors:  Osvaldo J Rivera-Gonzalez; Malgorzata Kasztan; Jermaine G Johnston; Kelly A Hyndman; Joshua S Speed
Journal:  Can J Physiol Pharmacol       Date:  2020-02-21       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.